Accessibility links
FDA Orders Arthritis Drug Bextra off the Market The Food and Drug Administration announces it is ordering the maker of Bextra to pull the painkiller off the market. The agency says incidences of serious reactions to the drug -- some of which have resulted in death -- outweigh the possible benefits. The FDA also is asking that other Cox-2 inhibitors such as Celebrex carry stronger warning labels.

Health

FDA Orders Arthritis Drug Bextra off the Market

Heard on Morning Edition

FDA Orders Arthritis Drug Bextra off the Market

Listen
  • Download
  • <iframe src="https://www.npr.org/player/embed/4581093/4581094" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">

The Food and Drug Administration announces it is ordering the maker of Bextra to pull the painkiller off the market. The agency says incidences of serious reactions to the drug — some of which have resulted in death — outweigh the possible benefits. The FDA also is asking that other Cox-2 inhibitors such as Celebrex carry stronger warning labels.